Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Silverback Therapeutics Inc (SBTX)

Silverback Therapeutics Inc (SBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Silverback Therapeutics Inc. is a clinical-stage biopharmaceutical company. Its ImmunoTAC technology platform, develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections and other serious diseases. Silverback Therapeutics Inc. is based in Seattle, United States.

Income Statement

(Values in U.S. Thousands) Sep, 2022 Jun, 2022 Mar, 2022 Dec, 2021 Sep, 2021
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -17,860 -19,430 -24,630 -23,460 -22,660
Net Income Growth +8.08% +21.11% -4.99% -3.53% +7.51%

Balance Sheet

(Values in U.S. Thousands) Sep, 2022 Jun, 2022 Mar, 2022 Dec, 2021 Sep, 2021
Total Assets 271,060 294,000 312,470 333,470 352,560
Total Assets Growth -7.80% -5.91% -6.30% -5.41% -3.93%
Total Liabilities 3,990 15,210 19,240 19,650 20,430
Total Liabilities Growth -73.77% -20.95% -2.09% -3.82% +17.89%

Cash Flow

(Values in U.S. Thousands) Sep, 2022 Jun, 2022 Mar, 2022 Dec, 2021 Sep, 2021
Operating Cash Flow -51,480 -34,900 -19,740 -66,760 -45,460
Operating Cash Flow Growth -47.51% -76.80% +70.43% -46.85% -72.59%
Net Cash Flow -50,820 -35,360 -20,060 -132,620 -85,910
Change in Net Cash Flow -43.72% -76.27% +84.87% -54.37% -219.61%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.